Wang Y, Jia R, Si H, Ma Y, et al. Efficacy and safety of sintilimab plus bevacizumab and CAPOX as first-line treatment for patients with RAS-mutant, microsatellite stable, metastatic colorectal cancer. BMC Cancer 2025;25:422.
PMID: 40055652